Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity

被引:0
|
作者
Benjamin Anon
Bérenger Largeau
Alban Girault
Aurélie Chantome
Morgane Caulet
Clémence Perray
Driffa Moussata
Christophe Vandier
Chantal Barin-Le Guellec
Thierry Lecomte
机构
[1] Hôpital Trousseau,Department of Gastroenterology and Digestive Oncology, Service d’Hépato
[2] CHRU de Tours,gastro
[3] Hôpital Bretonneau,entérologie
[4] CHRU de Tours,Department of Molecular Biology
[5] UMR CNRS 7292 (GICC),undefined
[6] Université François Rabelais,undefined
[7] INSERM,undefined
[8] UMR 1069,undefined
[9] Université François Rabelais,undefined
[10] INSERM,undefined
[11] UMR 850,undefined
[12] Université de Limoges,undefined
来源
关键词
Neuropathy; Platinum; KCNN3; SK3 channel; Oxaliplatin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:149 / 157
页数:8
相关论文
共 36 条
  • [1] Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
    Anon, Benjamin
    Largeau, Berenger
    Girault, Alban
    Chantome, Aurelie
    Caulet, Morgane
    Perray, Clemence
    Moussata, Driffa
    Vandier, Christophe
    Barin-Le Guellec, Chantal
    Lecomte, Thierry
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) : 149 - 157
  • [2] A CAG REPEAT POLYMORPHISM OF KCNN3 PREDICTS SK3 CHANNEL FUNCTION AND COGNITIVE PERFORMANCE IN SCHIZOPHRENIA
    Ehrenreich, Hannelore
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 70 - 70
  • [3] A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia
    Grube, Sabrina
    Gerchen, Martin F.
    Adamcio, Bartosz
    Pardo, Luis A.
    Martin, Sabine
    Malzahn, Doerthe
    Papiol, Sergi
    Begemann, Martin
    Ribbe, Katja
    Friedrichs, Heidi
    Radyushkin, Konstantin A.
    Mueller, Michael
    Benseler, Fritz
    Riggert, Joachim
    Falkai, Peter
    Bickeboeller, Heike
    Naue, Klaus-Armin
    Brose, Nils
    Stuehmer, Walter
    Ehrenreich, Hannelore
    EMBO MOLECULAR MEDICINE, 2011, 3 (06) : 309 - 319
  • [4] Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity
    Argyriou, Andreas A.
    Antonacopoulou, Anna G.
    Alberti, Paola
    Briani, Chiara
    Bruna, Jordi
    Velasco, Roser
    Anastopoulou, Garifallia G.
    Park, Susanna B.
    Cavaletti, Guido
    Kalofonos, Haralabos P.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, : 298 - 303
  • [5] Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity
    Basso, Michele
    Modoni, Anna
    Spada, Daniele
    Cassano, Alessandra
    Schinzari, Giovanni
    Lo Monaco, Mauro
    Quaranta, Davide
    Tonali, Pietro Attilio
    Barone, Carlo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1179 - 1187
  • [6] Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity
    Michele Basso
    Anna Modoni
    Daniele Spada
    Alessandra Cassano
    Giovanni Schinzari
    Mauro Lo Monaco
    Davide Quaranta
    Pietro Attilio Tonali
    Carlo Barone
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1179 - 1187
  • [7] The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
    Park, Susanna B.
    Lin, Cindy S-Y.
    Krishnan, Arun V.
    Kiernan, Matthew C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1189 - 1190
  • [8] The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
    Susanna B. Park
    Cindy S-Y. Lin
    Arun V. Krishnan
    Matthew C. Kiernan
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1189 - 1190
  • [9] Single Nucleotide Polymorphisms (SNPs) in KCNN3 (SK3 Channel) Associate with Preterm Birth
    Day, Lori J.
    Schaa, Kendra
    Murray, Jeffrey C.
    England, Sarah K.
    REPRODUCTIVE SCIENCES, 2010, 17 (03) : 255A - 256A
  • [10] The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects? reply
    Basso, Michele
    Modoni, Anna
    Lo Monaco, Mauro
    Barone, Carlo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (05) : 1191 - 1192